Technology Benefits
Simoa® technology detects single molecules of biomarkers in blood, offering unprecedented sensitivity and allowing for early identification of disease-related changes long before symptoms appear.
- 1000 times more sensitive than a traditional automated immunoassay analyzer
- Detect biomarkers at femtogram levels
- Transforms blood testing into a powerful tool for neurological disease detection
- Used in top research institutions and clinical trials for Alzheimer’s and other neurodegenerative diseases
- Reduces reliance on invasive procedures, offering a non-invasive, accessible alternative to CSF and PET imaging
Learn more
